December 14, 2016 07:37 AM ESTUpdated 10:15 AM
News Briefing

Pfiz­er inks an ear­ly-stage col­lab­o­ra­tion deal as it in­vests in an­oth­er start­up; Stem cell start­up lands car­diac tech

Shehla Shakoor

Managing Director

A busy Pfiz­er is part­ner­ing with South San Fran­cis­co-based Ab Ini­tio Bio­ther­a­peu­tics on the dis­cov­ery of new GPCR ac­ti­va­tor drugs. Pfiz­er is in­vest­ing in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Im­munol­o­gy biotech In­ma­gene to join Nas­daq through re­verse merg­er with what's left of Ike­na

A service from the Financial Times